Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $28.0 million.

  • Biote's Cash & Equivalents fell 2662.39% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year decrease of 2662.39%. This contributed to the annual value of $39.3 million for FY2024, which is 5579.65% down from last year.
  • Latest data reveals that Biote reported Cash & Equivalents of $28.0 million as of Q3 2025, which was down 2662.39% from $19.6 million recorded in Q2 2025.
  • Biote's 5-year Cash & Equivalents high stood at $89.0 million for Q4 2023, and its period low was $19.6 million during Q2 2025.
  • Over the past 5 years, Biote's median Cash & Equivalents value was $40.5 million (recorded in 2024), while the average stood at $51.2 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 26557.07% in 2022, then plummeted by 6142.09% in 2024.
  • Over the past 5 years, Biote's Cash & Equivalents (Quarter) stood at $26.8 million in 2021, then surged by 196.01% to $79.2 million in 2022, then increased by 12.33% to $89.0 million in 2023, then crashed by 55.8% to $39.3 million in 2024, then decreased by 28.71% to $28.0 million in 2025.
  • Its last three reported values are $28.0 million in Q3 2025, $19.6 million for Q2 2025, and $41.7 million during Q1 2025.